Exiqon Wins Ernst & Young Entrepeneur of the Year Award
News Nov 22, 2005
Exiqon A/S has announced that it has won the Ernst & Young Entrepreneur of the Year award in the category Biotech 2005.
The award is created to identify and acknowledge the successful and entrepreneurial Danish companies.
A minimum growth of 15% in sales as well as growth in staff is among the key nomination criteria.
Exiqon’s ProbeLibrary™ product as well as its miRCURY™ microRNA detection product line were key elements of growth of the company.
"We are very proud to receive this important award," says Lars Kongsbak, President and CEO of Exiqon.
"What we are seeing are the first results of Exiqon’s strategy to develop and market competitive products based on our LNA™ technology."
He adds, "We expect Exiqon’s revenue for 2005 to reach 5-6 million USD."
The Ernst & Young award follows a successful past year where the Exiqon CEO won the award as Biotech Builder of the year, and Exiqon was named among the Top 100 most Innovative companies worldwide by the magazine RedHerring.
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE
DNA Methylation Related to Liver Disease in Obese PatientsNews
DNA methylation implicated in initiation of liver fibrosis in non-alcoholic fatty liver diseaseREAD MORE
UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPONews
MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018